WHO ICTRP trial
Safety and efficacy of lobelin in the treatment of adults with moderate to…
ChiCTR2100047403 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100047403 |
|---|---|
| Public title | Safety and efficacy of lobelin in the treatment of adults with moderate to severe acute respiratory distress syndrome (ARDS) |
| Scientific title | Safety and efficacy of lobelin in the treatment of adults with moderate to severe acute respiratory distress syndrome (ARDS) |
| Primary sponsor | The Third Affiliated Hospital of Sun Yat-Sen University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | acute lung injury and acute respiratory distress syndrome |
| Interventions | Experimental group:Lobelin;Control group:conventional therapy |
| Registration date | Jun 18, 2021 |
| Target size | Experimental group:10;Control group:6 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: